09:58 AM EST - Cipher Pharmaceuticals Inc. : Announces the state of Illinois has updated its Preferred Drug Listing ("PDL") where Cipher's product Natroba™, for the treatment of scabies and head lice, has obtained preferred drug status on Medicaid state plans, and whereby its main competitive product Permethrin 5% has been downgraded to non-preferred status. As a result of this change, all Medicaid treatments for scabies and Permethrin 5% prescriptions in the state must first step through Natroba™ being the preferred treatment in Illinois. Cipher Pharmaceuticals Inc.
shares T.CPH are trading up $0.25 at $12.64.
